Alzheimer's Disease International (ADI) is a company within the Non-Profit Organization category. Alzheimer's Disease International (ADI) is the international federation of Alzheimer associations throughout the world. Founded in 1984, it works to raise awareness about dementia, advocate for policy change at the global level, and support the development of national Alzheimer associations.
Alzheimer's Disease International (ADI) was founded in 1984 and is headquartered in London, UK.
Alzheimer's Disease International (ADI) is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Alzheimer's Disease International (ADI) is Strong. Significant factual deltas detected.
AI models classify Alzheimer's Disease International (ADI) as a Challenger. AI names competitors first.
Alzheimer's Disease International (ADI) appeared in 5 of 6 sampled buyer-intent queries (83%). ADI dominates branded queries but is occasionally secondary to national associations (like the US Alzheimer's Association) on broad 'dementia advocacy' terms.
The brand is perceived as a high-authority, credible international NGO. AI reliably identifies its mission and global status but may struggle with real-time data regarding specific regional member associations or recent policy wins. Key gap: The most significant gap is the exact number of member associations, which changes annually as new national groups join or reach full membership status.
Of 5 key facts verified about Alzheimer's Disease International (ADI), 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Current leadership names (CEO/Chair) and specific annual funding figures are likely to be outdated in AI responses.
Buyers turn to Alzheimer's Disease International (ADI) for Internal Government Programs: Managing care and advocacy through internal government health departments or local community volunteers without a global framework., Healthcare Consulting Firms: Hiring specialized healthcare consulting firms to develop national dementia strategies., Localized Fragmented Advocacy: Allowing local alzheimer's chapters to operate in silos without international coordination or knowledge sharing., among 3 documented problem areas.
Buyers evaluating Alzheimer's Disease International (ADI) typically ask AI models about "international alzheimer's federation", "global dementia policy advocacy", "who is in official relations with WHO for dementia", and 3 similar queries.
Alzheimer's Disease International (ADI)'s main competitors are Alzheimers Research Uk. According to AI models, these are the brands most frequently named alongside Alzheimer's Disease International (ADI) in buyer-intent queries.
Alzheimer's Disease International (ADI)'s core products are Advocacy, World Alzheimer Report, World Alzheimer's Month, Accreditation of national associations..
Alzheimer's Disease International (ADI) uses Membership-based (for associations) / Free Public Resources.
Alzheimer's Disease International (ADI) serves National Alzheimer associations, health ministries, global policy makers, and dementia researchers..
Alzheimer's Disease International (ADI) The only global federation that unites national Alzheimer associations into a single voice for policy change at the WHO and UN levels.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/alzheimers-disease-international-adi
Last analyzed: April 10, 2026
Founded: 1984
Headquarters: London, United Kingdom